1. Home
  2. FGEN vs POCI Comparison

FGEN vs POCI Comparison

Compare FGEN & POCI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FGEN
  • POCI
  • Stock Information
  • Founded
  • FGEN 1993
  • POCI 1982
  • Country
  • FGEN United States
  • POCI United States
  • Employees
  • FGEN N/A
  • POCI N/A
  • Industry
  • FGEN Biotechnology: Pharmaceutical Preparations
  • POCI Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • Sector
  • FGEN Health Care
  • POCI Health Care
  • Exchange
  • FGEN Nasdaq
  • POCI Nasdaq
  • Market Cap
  • FGEN 38.4M
  • POCI 35.1M
  • IPO Year
  • FGEN 2014
  • POCI N/A
  • Fundamental
  • Price
  • FGEN $11.14
  • POCI $4.36
  • Analyst Decision
  • FGEN Strong Buy
  • POCI
  • Analyst Count
  • FGEN 2
  • POCI 0
  • Target Price
  • FGEN $146.50
  • POCI N/A
  • AVG Volume (30 Days)
  • FGEN 37.7K
  • POCI 4.0K
  • Earning Date
  • FGEN 11-11-2025
  • POCI 11-13-2025
  • Dividend Yield
  • FGEN N/A
  • POCI N/A
  • EPS Growth
  • FGEN N/A
  • POCI N/A
  • EPS
  • FGEN N/A
  • POCI N/A
  • Revenue
  • FGEN $7,346,000.00
  • POCI $17,626,155.00
  • Revenue This Year
  • FGEN N/A
  • POCI N/A
  • Revenue Next Year
  • FGEN N/A
  • POCI N/A
  • P/E Ratio
  • FGEN N/A
  • POCI N/A
  • Revenue Growth
  • FGEN N/A
  • POCI N/A
  • 52 Week Low
  • FGEN $4.50
  • POCI $3.47
  • 52 Week High
  • FGEN $21.94
  • POCI $6.59
  • Technical
  • Relative Strength Index (RSI)
  • FGEN 53.16
  • POCI 37.43
  • Support Level
  • FGEN $11.12
  • POCI $4.15
  • Resistance Level
  • FGEN $12.53
  • POCI $4.65
  • Average True Range (ATR)
  • FGEN 0.89
  • POCI 0.19
  • MACD
  • FGEN -0.16
  • POCI -0.03
  • Stochastic Oscillator
  • FGEN 30.48
  • POCI 28.00

About FGEN FibroGen Inc

FibroGen Inc is a biotechnology company focused on discovering, developing, and commercializing novel therapeutics to treat serious cancer biology and anemia. The company operates in one reportable segment: the development and commercialization of novel therapeutics to treat serious unmet medical needs. The company generates the vast majority of its revenue in Europe, followed by Japan. Virtually all of FibroGen's revenue to date has been generated from its collaboration agreements. FibroGen seeks partners with research, development, and marketing capabilities and other resources that strengthen the company's ability to advance product candidates. Geographically, it operates in United States, Japan, Europe and Others.

About POCI Precision Optics Corporation Inc.

Precision Optics Corp Inc is engaged in designing, developing, and manufacturing advanced optical instruments. It manufactures medical products such as endoscopes and endocouplers which incorporate various optical technologies for use in a variety of minimally invasive surgical and diagnostic procedures. The company also produces endoscopes for various applications as well as designs and manufactures custom optical medical devices to satisfy customers' specific requirements. In addition, the company manufactures and sells components and assemblies specially designed for industrial and military use. The company earns the majority of its revenue from the United States.

Share on Social Networks: